NFKB1 and familial pancreatic carcinoma: Our immunoblot data demonstrated that honokiol treatment caused a marked and dose-dependent decrease in NF-κB levels in the nuclear fraction of both MiaPaCa and Panc1 pancreatic cancer cells with a simultaneous increase in the cytoplasmic fraction (Figure 6B).